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Summary
As survival is now increasing, care of the extremely preterm infant is now
directed at strategies to minimize long-term morbidity. In this study, I review
the current state-of-the-art outcomes for babies born at extremely low gesta-
tions and identify strategies that may be aimed at optimizing outcomes. With
respect to anesthetic practice, I then go on to discuss important issues of pain
management in these babies and how this may affect long-term outcomes.
Introduction
Care of babies born at very low gestations or with
important but potentially correctable malformations has
always provoked challenging ethical and moral
dilemmas as survivors have high prevalence of serious
and lifelong sequelae. Particularly at extremely low
gestations, we have seen major improvements in sur-
vival, which render decision-making more difficult and
throw the adverse long-term outcomes into greater
focus. Neonatologists have been effective at describing
the sequelae associated with very preterm birth, and
outcome evaluation programs run in many countries,
both in terms of national and regional outcomes and as
either primary or safety outcomes for important
multicenter clinical trials.
Increasingly, neonatal practice is oriented to minimiz-
ing adverse late sequelae. Management strategies have
developed to protect the developing brain, lung, and gut
in particular, to minimize the effects of our care on these
outcomes. Such strategies form an important part of the
current philosophy of neonatal care, and in this paper I
will address the issue of important long-term outcomes
and how we might modify or study anesthetic and
perioperative care to understand better the effect that
our intervention has on the developing child. Analgesic
and anesthetic agents are not necessarily safe in the
developing child; perioperative management may
provide high exposure to multiple risk factors, and thus,
it is critical that we take steps to optimize practice to
produce minimal risk of sequelae.
I will begin by describing current outcomes for the
highest risk groups and then evaluate the long-term
effects of different management strategies on key organ
systems in the very preterm baby, emphasizing
perioperative and intraoperative care issues. Separating
out the effects of premorbid conditions, for example
congenital anomalies, known areas of risk (such as very
preterm birth or perinatal hypoxia-ischemia), surgical
procedures, and anesthetic strategies, is challenging, and
a consistent approach to outcome-directed care is
important for each.
Outcome in very preterm infants
There is now a large literature on outcomes for babies
born before 32 weeks (very preterm) and 28 weeks
(extremely preterm; EP) (1). Survival has improved over
the past 15 years for the most immature, rising by 15%
between 1995 and 2006, despite a 44% increase in the
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numbers of admissions for babies 22–25 weeks (2);
survival is now the norm for babies of 27 weeks and
more, rising from 60% at 24 weeks (3).
Neurocognitive morbidity
Of more concern are the relatively frequent findings of a
range of neurological and behavioral problems among
survivors. All adverse outcomes are inversely related to
gestational age at birth and seem to be particularly
problematic at gestations below 30 weeks. Data from
the most recent EPICure 2 study describe outcomes for
births in 2006, shown in Figure 1 alongside contempor-
ary data from Sweden (4). Key findings at 22–25 weeks
of gestation, compared with outcomes in the original
EPICure study of births in 1995, are as follows:
• An improvement in developmental scores by eight
points.
• Reduction in cerebral palsy and impairment rates in
babies born between 24 and 25 weeks (Figure 1).
• Continuing low rates of severe cerebral palsy (Fig-
ure 2).
• Increasing numbers of survivors without impairment
born between 24 and 25 weeks.
Although the risk of severe and moderate impair-
ments appears to be declining and drives decision-mak-
ing in the neonatal period, there remains a high
prevalence of less severe impairments of cognitive, learn-
ing, and behavior, which are equally a cause for con-
cern. These result in high rates of special educational
needs at school (5,6) and a high prevalence of behavior
problems (7). These may persist through adult life
although most ex-very low birthweight children are well
adjusted as young adults (8).
Respiratory morbidity
There are many fewer studies of morbidity in other
organ systems. In particular, the late sequelae of bron-
chopulmonary dysplasia (BPD) pose potential issues for
the growing child/young adult. High rates of readmis-
sion during infancy are reported, particularly following
RSV infection, and infants with neonatal BPD may
require further episodes of intensive care for respiratory
conditions. The high rate of readmission drops off, but
in our studies, symptoms are common, as are ongoing
medications over childhood. Furthermore, in early ado-
lescence, children with and without BPD have signifi-
cant impairment of lung function (9,10). Table 1 shows
differences between controls and EP children at
11 years. EP children were smaller compared with class-
mate controls and had significantly more symptoms and
poorer respiratory function. Children with neonatal
BPD were similar to those without BPD in terms of
symptoms and medication use but had significantly
worse measured respiratory function. Current studies
are directed at determining how lung function changes
over adolescence into young adult life, as it seems likely
that ex-preterm children will enter adulthood with less
optimal maximal respiratory function and therefore be
at risk of earlier onset of chronic respiratory symptoms,
Figure 1 Outcome at extremely low gestational age at 3 years in
two national cohorts from England (EPICure2; E2) (4) and Sweden
(EXPRESS; Ex) (59).
Figure 2 Prevalence and severity of cerebral palsy in a national
cohort study classified using Gross Motor Function Classification
System (0: no Cerebral palsy; 1 mild impairment; 2: moderate impair-
ment; 3–4 severe impairment) (4).
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particularly if they have ongoing inflammation or they
smoke (11).
Management and preterm outcomes
It is important to maintain a perspective on long-term
outcomes during neonatal management as key areas of
practice have unexpectedly led to therapeutic misadven-
ture – classically in the unrestricted use of oxygen lead-
ing to retinopathy of prematurity (12), but more
recently in the association between cerebral palsy and
antepartum antibiotics (13). In these terms, neonatolo-
gists have developed strategies to minimize risks,
primarily around brain and lung injury (Table 2), and
many neonatal, and indeed perinatal studies, now
include, as a minimum, 2-year evaluation as a coprimary
or safety outcome.
There is a general consensus that long-term outcomes
should be measured after 18 m-2 years because neuro-
logical and developmental tests are more likely to have
some predictive value at those ages. There is agreement
over the description of impairment in preterm popula-
tions at around 2 years (14). However well the predic-
tion performs in populations, for individuals, it is much
less accurate (15), and longer-term studies are needed if
more subtle outcomes are expected or formal respiratory
function testing undertaken. Longer-term evaluations
run the risk of study dropout and dilution of the
therapeutic effect with social and environmental influ-
ences. For example, in a recent large trial of caffeine to
prevent apnea, advantages seen over the first 2 years
were not detectable at 5 years (16). This does not mean
that one can ignore the early findings in view of the loss
to follow-up and external influences, but rather gives
confidence that harm is unlikely and the short-term
gains need to be weighed up against potential neonatal
side effects.
The extent to which individual changes in manage-
ment alter long-term outcomes outside of a random-
ized trial is somewhat debatable, but a range of
altered management strategies as a result of neonatal
research, encompassing many aspects of neonatal
care, accompanied the changes in outcome between
1995 and 2006 described above. There is evidence that
changes in long-term outcomes may lag behind
changes in mortality (17), which is only logical, but
survival is improving dramatically in developed coun-
tries (3,18) and within expert centers (19,20). Thus, it
seems logical that we should modify our practice to
optimize long-term outcomes.
Anesthesia and preterm outcomes
Anesthetic practice interacts with small preterm babies,
not simply during perioperative care but also where
stand-alone surgical units undertake neonatal surgery,
which is not a recommended service configuration (21).
Outside the perioperative period, there is no reason why
intensive care should not be continued to the same stan-
dard as during neonatal care, and it seems logical for
such units to contribute to neonatal data collection and
national/regional audit as do medical intensive care ser-
vices. Standards for surgical services in the UK have
been published which support this position (21). This is
very important as it allows continuance of research pro-
tocols during periods of neonatal surgical intensive care,
Table 1 Respiratory morbidity and function following extremely preterm (EP) birth at 11 years (9)
Parameter
Differences between
EP vs. controls
EP children with
BPD
EP children without
BPD
Differences between
BPD vs. No BPD
Growth
Height (Z score) 0.58 (95%CI: 0.8; 0.4)*** 0.47 (SD: 0.99) 0.48 (SD: 0.98) 0.00 (0.3; 0.3)
Weight (Z score) 0.57 (95%CI: 0.8; 0.3)*** 0.37 (SD: 1.31) 0.49 (SD: 1.25) 0.13 (0.3; 0.5)
BMI (Z score) 0.39 (95%CI: 0.7; 0.1)** 0.22 (SD: 1.4) 0.39 (SD: 1.4) 0.17 (0.28, 0.62)
Respiratory symptoms
Current asthma 12% (95%CI: 4; 21%)** 32 (28%) 10 (19%) 9% (5; 22%)
Asthma medication 14% (95%CI: 6; 22%)** 31 (27%) 10 (19%) 8% (6; 21%)
Seen by respiratory specialist 6% (95%CI: 1; 11%)* 7 (6%) 7 (14%) 8% (20; 3%)
Wheeze 7% (95%CI: 2; 15%) 29 (25%) 6 (12%) 13% (2; 25%)*
Spirometry
FEV1 (Z score) 1.5 (95%CI: 1.7; 1.2)*** 1.7 (SD: 1.1) 0.8 (SD: 1.3) 0.9 (1.2; 0.5)***
FEF25–75% (Z score) 1.5 (95%CI: 1.8; 1.2)*** 2.2 (SD: 1.2) 1.5 (SD: 1.4) 0.7 (1.1; 0.3)***
%D postbronchodilator 5.3% (95%CI: 3.5; 7.0)*** 10.7% (SD: 10.0) 5.5% (SD: 7.3) 5.2% (2.0; 8.5)**
DFEV1 >12% 19% (95%CI: 11; 27)*** 32% 16% 16% (3; 30)*
BPD, bronchopulmonary dysplasia.
*P < 0.05; **P < 0.01; ***P < 0.001.
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for example in the recent BOOST-II UK trial of oxygen
saturation targeting (22).
Separating out influences of perioperative care in the
complex clinical journey of a sick very preterm infant is
challenging, and ascribing outcomes to care over these
periods is difficult. Nonetheless, similar key strategies as
set out in Table 2 should be continued during this per-
iod. Perioperative care has several key areas where these
principles should be continued wherever possible, exam-
ples being:
• Targetting oxygen saturations (minimizing risk of
retinopathy).
• Avoiding fluctuations in blood pressure (minimize
risk of brain injury).
• Use of caffeine and careful fluid balance (minimize
risk of exacerbating lung injury).
• Gentle ventilation and avoidance of over-distension
(minimize barotrauma).
• Ensuring high quality nutritional input pre- and
postoperatively.
Conditions presenting to surgical services bring their
own challenges in this patient group, the largest groups
being those with necrotizing enterocolitis (NEC) and
patent ductus arteriosus (PDA).
Necrotizing enterocolitis is a devastating condition
associated with widespread inflammatory activation and
circulatory collapse. Maintaining outcome-focused care
during the period of critical illness is challenging (23),
and the neurological, nutritional and respiratory
outcomes for babies with surgically treated NEC may be
particularly compromised, simply due to the underlying
pathological process.
Patent ductus arteriosus is a common condition with
frequent referral for surgical ligation. Such babies have
often been difficult to wean from ventilation and may
pose considerable ventilation and fluid management
challenges, with important knock on effects for chronic
lung disease. The use of ligation shows much variation
between different services and practice needs to be ratio-
nalized to minimize the additional risk posed by the
transfer and surgery (24).
One study has attempted to dissect the influences of
surgery for NEC on term-equivalent brain magnetic
resonance imaging (MRI), using the latter as a biomar-
ker for later neurodevelopment. Filan et al. (25) used a
convenience cohort of 227 babies of <30 weeks gestation
who had MRI scans at term. Thirty of these had been
exposed to surgery and anesthesia, most herniotomy
(n = 15) but eight had surgery for bowel problems and
Table 2 Examples of outcome-directed treatments for the very preterm newborn
Organ/target Intervention Putative mechanism References
Brain
Germinal matrix hemorrhage Antenatal Steroid Improved early condition, induces antioxidants (43)
Indomethacin (prophylaxis) Unknown (reduces large GMH) (44)
Cerebral palsy Magnesium sulfate in labor Cellular neuroprotection (NMDA blocker) (45)
CP/Developmental scores Caffeine Unknown (reduction in PDA and diuretic effect
via respiratory improvement)
(46)
Developmental scores Avoid long line infection Reduced inflammatory white matter injury (47)
Eye
Retinopathy of prematurity Targeted oxygen
saturation (90–94%)
Avoid oxygen fluctuation/extremes (22,48)
Lung
Respiratory distress syndrome Antenatal Steroid Induces surfactant and antioxidants, reduces lung water (43)
Surfactant Easier lung inflation (49)
Bronchopulmonary dysplasia Caffeine Diuretic and avoidance of patent duct (46)
Early extubation Reduce barotrauma (50)
Minimize ventilator pressure/Ti Reduce volutrauma (51)
Early moderate PEEP Reduce atelactotrauma (52)
Optimal nutrition Encourage lung repair (53)
Vitamin A Encourage lung repair (54)
Perfusion
Circulatory filling Placental transfusion Reduces large GMH (55)
Gut
Adaptation Early colostrum Earlier feeding (56)
Necrotizing enterocolitis Probiotics Avoids enteropathic organisms (57)
Early colostrum Encourages gut coordination/adaptation (56)
Early TPN Avoids need for aggressive feeding (58)
PDA, patent ductus arteriosus.
© 2013 The Authors. Pediatric Anesthesia published by John Wiley & Sons Ltd.
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10 ligation of PDA. Babies exposed to surgery had more
evidence of white mater injury and smaller brain vol-
umes, particularly in the deep gray matter. Developmen-
tal scores after appropriate adjustment were not
different between the groups, but the power of this
opportunistic study was small, and in the absence of
randomized methodology, it is impossible to separate
out premorbid, surgical, and anesthetic influences. Evi-
dence based approaches to anesthetic management in
surgery for the preterm infant are urgently required.
Management of pain
The seminal study in perioperative care, which high-
lighted the clear physiological and metabolic response to
surgery, was carried out by Anand et al. (26) in 1987.
Preterm babies receiving PDA ligation were randomly
allocated to anesthesia with oxygen/nitrous oxide (as
conventional) or to additional fentanyl analgesia. The
clear outcomes in favor of fentanyl spawned a contin-
uing interest and activity in neonatal pain and stress.
More recently, we have demonstrated altered sensory
perception at 11 years following EP birth that was most
extreme among babies exposed to surgical procedures
(27). Minimizing the perception and metabolic conse-
quences of neonatal pain may therefore have short-term
and lifelong benefit.
Important studies of long-term effects of neonatal
nociception are ongoing. The group in Vancouver have
identified the number of skin breaks during neonatal
intensive care as a marker of allostatic load. Although
this may be a poor surrogate for nociception, after con-
trolling for other intensive care confounders, the num-
ber of skin breaks has been correlated with changes in
white matter and subcortical gray matter spectroscopy
on MRI, suggesting a differential effect of timing on
both structures (28). Summative measures of illness and
the number of skin breaks were also associated with
slower development of white matter fractional anisot-
ropy (29). Skin breaks also were associated with later
changes on magnetoencephalography (MEG) (30),
poorer postnatal growth (31), and behavioral measures
(32). Although referred to as a measure of neonatal
‘pain’, it is unclear how the number of skin breaks
relates to other measures of stress and to what extent it
is simply a more proximal measure of neonatal sickness.
Nonetheless, these studies do raise important questions
and hypotheses as to the effects of neonatal pain and the
benefit of their amelioration (33). Changes in term-age
equivalent MRI scans may translate into later neurocog-
nitive morbidity.
Other areas of neonatal pain research have confirmed
that even the very preterm newborn can develop
appropriate stress and metabolic responses to nocicep-
tive stimuli, even if it may be difficult to observe them
clinically (34). Much pain research has concentrated on
procedural pain from heel prick or circumcision as con-
trollable events, hence outcomes tend to be short-term
and analgesic strategies probably insufficient to be
considered for major surgical procedures requiring
anesthetics.
Several groups have attempted to study the effect of
analgesia in clinical intensive care practice. Levene and
colleagues (35) studies the effect of morphine com-
pared with diamorphine in a group of preterm new-
borns undergoing mechanical ventilation. There were
minor differences between the two drugs, and mor-
phine was associated with a fall in blood pressure over
the course of the infusion, but there was equivalence in
the responses as measured, and both reduced plasma
epinephrine levels. In an earlier study, they had studied
morphine against placebo (36) and observed at 5 years
of age that there was no evidence of significant long-
term benefit or harm; they noted that the morphine
group tended to have better neurocognitive scores
compared with controls. In the largest study of pre-
emptive morphine in 898 preterm babies receiving
mechanical ventilation (37), Anand et al. reported that
morphine decreased the clinical signs of pain (as mea-
sured though the preterm infant pain profile and clini-
cal variables) but had little effect on neonatal
morbidities. In secondary analyses, worse outcomes
(including an excess of germinal matrix hemorrhages)
were evident in morphine treated babies of <26 weeks
of gestation. No long-term follow-up has been reported
to date.
Several small studies have evaluated morphine, syn-
thetic opioids, and other anesthetic agents (such as
propofol) for intubation procedures with varying
results. All use short-term outcomes.
Thus, in summary, we have little evidence that anal-
gesia per se benefits the ventilated preterm baby in the
long term, and only one randomized trial during sur-
gery, demonstrating clear superiority of opioid analge-
sia over the then conventional oxygen/nitrous oxide
method, but with only short-term outcomes. Perioper-
ative opioid analgesia has been recommended for liga-
tion of PDA (24), and this is supported in the original
trial. Pain itself in the preterm baby produces short-
term clinical, metabolic, and endocrinological stress
and would seem to be associated with neurological
abnormalities on MRI and impaired long-term sensi-
tivity, thus systemic analgesia seems appropriate but
there remains a dearth of evidence as to the most
appropriate drug and strategy, and little evidence that
long-term outcomes are affected.
© 2013 The Authors. Pediatric Anesthesia published by John Wiley & Sons Ltd.
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Direct toxic effects of anesthetic agents
Working from first principles that analgesia is good is
fine as long as there is confidence in the safety of the
agents used. Morphine (35), alfentanyl (38), and other
opioid agents have been associated with cardiovascu-
lar adverse events and should be used with care and
monitoring. Of more concern is the preclinical work
that indicated the association of apoptosis with the
administration of NMDA blockers, such as ketamine
(39). Subsequently, nitrous oxide, midazolam, propo-
fol, and isofluorane have all been found to produce
similar effects in infant rodent models, associated with
NMDA blockade and GABAA agonists (40). Indeed,
only dexmedetomidine seems not to be associated with
the generation of apoptosis. Further studies have
demonstrated long-term cognitive effects in these
rodent models from ketamine, phenobarbitone, and
inhalational anesthetics (40). There is equally a large
body of evidence that morphine may also induce simi-
lar changes even allowing for a different mode of
action.
Evaluating putative effects of anesthetic agents in
human studies is considerably more difficult, particu-
larly as there are unlikely to be randomized trials against
placebo, and many other influences conspire to put the
very preterm baby at risk of later neuromorbidity. In a
large group of studies largely not structured to assess
specific effects of individual agents, the need for surgery
is associated with adverse outcomes (41). Furthermore,
to demonstrate differences in neurological outcomes
requires large trial sizes, and disentangling the effect of
sedation/anesthesia from the reasons for the therapy is
nigh on impossible, although putative designs have been
proposed (42).
Selection of babies for anesthetic/surgical procedures
demands a careful risk benefit assessment. Whereas it is
unclear as to the extent of direct toxic effect from
agents used, there is a clear need to provide adequate
analgesia/anesthesia during procedures. For relatively
frequent conditions, such as PDA ligation, preterm
laparotomy, or herniotomy, there should be sufficient
patient numbers in large surgical services to facilitate
comparison of different techniques and harnessing neo-
natal follow-up services to provide long-term outcomes
is entirely possible. Local and regional anesthesia and
minimally invasive techniques may help to minimize
exposure to systemic drugs and minimize long-term
risk; they may be relatively easily subjected to random-
ized trials and with appropriate stratification, for exam-
ple, by gestational age, may help to answer some of the
conundrums posed above.
Conclusions
Increasingly anesthetic practice interfaces with the EP
baby for periods of perioperative or intensive care. Over
the past 10 years, our understanding of the pathophysi-
ology and potential for iatrogenic harm has grown,
alongside the need to provide care with a view to opti-
mizing longer-term outcomes. Sick immature babies
remain one of the major challenges in pediatric anesthe-
sia as in neonatology.
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